Get in touch

Find out more about our partnering teams and the right person to contact.


Organisational structure

Our business development and partnering teams are embedded within our R&D and portfolio strategy units. This allows us to combine our scientific and commercial insight with our business development expertise to create the right partnerships that offer greatest value for us, for our partners and for patients.


Downloads

Download our 2016 partnering brochure and a printable version of the contact sheet for our business development teams. 


Contact Directory

Biotech units

Early-stage opportunities up to, and including, Phase 1

Our biotech partnering teams are focused on sourcing early-stage opportunities that are a strategic fit with our therapy area portfolio and innovative scientific capabilities. Designed to improve innovation and accelerate decision-making, we have created autonomous biotech units for both small molecules (Innovative Medicines and Early Development – IMED) and biologics (MedImmune) research. These research units are focused on pioneering science that will have a transformational impact on health outcomes for patients.

IMED

  • Business Development Leadership

  • Respiratory, Inflammation & Autoimmunity

  • Cardiovascular & Metabolic diseases

  • Oncology

  • Neuroscience

  • External Collaborations (Government/University/Non-profit)

  • Technology

  • Out-licensing/ Spin-outs

MedImmune

  • Business Development Leadership

    Eric Victory

    Interim Vice-President, Biotech Partnering & Strategy, MedImmune

    Gaithersburg, USA VictoryE@medimmune.com
  • Respiratory, Inflammation & Autoimmunity

    Eric Paradise

    Senior Director, Biotech Partnering & Strategy, MedImmune

    Gaithersburg, USA ParadiseE@medimmune.com
  • Cardiovascular & Metabolic diseases

  • Oncology

  • Infection

    Derek Woodward

    Associate Director, Biotech Partnering & Strategy, MedImmune

    Gaithersburg, USA WoodwardD@medimmune.com
  • Neuroscience

    Philip Oliver

    Director, Biotech Partnering & Strategy, MedImmune

    Gaithersburg, USA OliverP@medimmune.com
  • External Collaborations (Government / University / Non-profit)

    Jarrod Borkat

    Senior Director, Biotech Partnering & Strategy, MedImmune

    Gaithersburg, USA BorkatJ@medimmune.com
  • Technology

    Jung Lee

    Director, Biotech Partnering & Strategy, MedImmune

    Gaithersburg, USA LeeJu@medimmune.com
  • Out-licensing / Spin-outs

    Mickey Kim

    Director, Biotech Partnering & Strategy, MedImmune

    Gaithersburg, USA KimMic@medimmune.com

Global Product & Portfolio Strategy

Mid- to late-stage opportunities, Phase 2 & beyond

Our Global Product and Portfolio Strategy (GPPS) group maximises the value of our mid- to late-stage portfolio across small molecules and biologics, by providing clear strategic direction from development through to commercialisation and life-cycle management.

Search & Evaluation

Our specialist Search & Evaluation colleagues are embedded within our Therapy Area teams, and are supported by dedicated deal-making and corporate development centres of excellence.

Business Development Operations

Our Business Development Operations team provides world-class capabilities in due diligence and creative deal-making, including personalised healthcare and alliance and integration management.

Corporate Strategy & Development

Our Corporate Strategy & Development team sets the long-term direction of the company to maintain our financial and commercial competitiveness, including transformational M&A, global opportunities in new areas of business, and geographic opportunities in key markets or regions.